Literature DB >> 2125239

Purine salvage enzyme activities in normal and neoplastic human tissues.

M Camici1, M G Tozzi, S Allegrini, A Del Corso, O Sanfilippo, M G Daidone, C De Marco, P L Ipata.   

Abstract

The enzymatic pattern of five enzymes involved in the purine salvage pathway, namely purine nucleoside phosphorylase (EC 2.4.2.1), adenosine deaminase (EC 3.5.4.4), 5'-nucleotidase (EC 3.1.3.5), alkaline phosphatase (EC 3.1.3.1), and hypoxanthine-guanine phosphoribosyltransferase (EC 2.4.2.8) has been evaluated both in human intestinal and breast carcinomas and compared to that of normal tissues. A higher level of hypoxanthine-guanine phosphoribosyltransferase was associated with tumor tissues. This metabolic alteration should lead to an elevated synthesis of nucleotides in cancer cells, might confer selective growth advantages to neoplastic tissues, and account, at least in part, for the difficulties encountered in the chemotherapy of human tumors, by using compounds affecting only the purine de novo biosynthesis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2125239

Source DB:  PubMed          Journal:  Cancer Biochem Biophys        ISSN: 0305-7232


  15 in total

1.  Elevated adenosine deaminase levels in celiac disease.

Authors:  Basak Cakal; Yavuz Beyazit; Seyfettin Koklu; Erdem Akbal; Ibrahim Biyikoglu; Gulsen Yilmaz
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

2.  Adenosine deaminase in saliva as a diagnostic marker of squamous cell carcinoma of tongue.

Authors:  Balwant Rai; Jasdeep Kaur; Reinhilde Jacobs; Suresh Chander Anand
Journal:  Clin Oral Investig       Date:  2010-04-09       Impact factor: 3.573

3.  Activities of adenosine deaminase and 5'-nucleotidase in cancerous and noncancerous human colorectal tissues.

Authors:  A Eroglu; O Canbolat; S Demirci; H Kocaoglu; Y Eryavuz; H Akgül
Journal:  Med Oncol       Date:  2000-11       Impact factor: 3.064

4.  Activities of adenosine deaminase, 5'-nucleotidase, guanase, and cytidine deaminase enzymes in cancerous and non-cancerous human breast tissues.

Authors:  O Canbolat; I Durak; R Cetin; M Kavutcu; S Demirci; S Oztürk
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

5.  Purification, characterization, and gene cloning of purine nucleosidase from Ochrobactrum anthropi.

Authors:  J Ogawa; S Takeda; S X Xie; H Hatanaka; T Ashikari; T Amachi; S Shimizu
Journal:  Appl Environ Microbiol       Date:  2001-04       Impact factor: 4.792

6.  Lipid peroxidation and antioxidant enzyme activities in cancerous bladder tissue and their relation with bacterial infection: a controlled clinical study.

Authors:  Nihayet Bayraktar; Suleyman Kilic; Mehmet Refik Bayraktar; Nurten Aksoy
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

7.  Adenosine deaminase, 5'-nucleotidase, xanthine oxidase, superoxide dismutase, and catalase activities in gastric juices from patients with gastric cancer, ulcer, and atrophic gastritis.

Authors:  I Durak; N Ormeci; O Akyol; O Canbolat; M Kavutçu; M Bülbül
Journal:  Dig Dis Sci       Date:  1994-04       Impact factor: 3.199

8.  Enzyme activities controlling adenosine levels in normal and neoplastic tissues.

Authors:  D Vannoni; A Bernini; F Carlucci; S Civitelli; M C Di Pietro; R Leoncini; F Rosi; A Tabucchi; G Tanzini; E Marinello
Journal:  Med Oncol       Date:  2004       Impact factor: 3.064

9.  Proteomic profiling reveals that resveratrol inhibits HSP27 expression and sensitizes breast cancer cells to doxorubicin therapy.

Authors:  José Díaz-Chávez; Miguel A Fonseca-Sánchez; Elena Arechaga-Ocampo; Ali Flores-Pérez; Yadira Palacios-Rodríguez; Guadalupe Domínguez-Gómez; Laurence A Marchat; Lizeth Fuentes-Mera; Guillermo Mendoza-Hernández; Patricio Gariglio; César López-Camarillo
Journal:  PLoS One       Date:  2013-05-27       Impact factor: 3.240

10.  Serum adenosine deaminase, catalase and carbonic anhydrase activities in patients with bladder cancer.

Authors:  Necip Pirinççi; Ilhan Geçit; Mustafa Güneş; Mehmet Bilgehan Yüksel; Mehmet Kaba; Serhat Tanık; Halit Demir; Mehmet Aslan
Journal:  Clinics (Sao Paulo)       Date:  2012-12       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.